Edition:
United States

Jessica Hall

Dealtalk: Suitors for Diamond brands have long wait to snack

Feb 20 2012

NEW YORK/PHILADELPHIA Food companies salivating over Diamond Foods Inc's Pop Secret popcorn and Kettle potato chips will want to wait for a full examination of the company's books to be completed, and by then Diamond may have cleaned up enough of its problems to not even put them on the table.

A Signet, Zale combo could sparkle

Feb 15 2012

PHILADELPHIA/NEW YORK Jewelry store operator Zale Corp is on the rebound after being left by customers and shunned by vendors during the recession, and its best hope to prosper may be a marriage to larger rival Signet Jewelers Ltd .

A Signet, Zale combo could sparkle

Feb 15 2012

PHILADELPHIA/NEW YORK, Feb xx Jewelry store operator Zale Corp is on the rebound after being left by customers and shunned by vendors during the recession, and its best hope to prosper may be a marriage to larger rival Signet Jewelers Ltd .

Illumina adopts poison pill to stave off Roche

Jan 26 2012

PHILADELPHIA/ZURICH U.S. gene sequencing company Illumina Inc adopted a "poison pill" defense strategy against a hostile $5.7 billion bid from Swiss drugmaker Roche Holding AG , saying it would trigger a rights agreement if any party bought 15 percent of its stock.

Dealtalk: Roche, Illumina hunker down for takeover battle

Jan 25 2012

LOS ANGELES/PHILADELPHIA Roche Holding AG's hostile bid for Illumina Inc , the market leader in gene sequencing technology, is likely to be a protracted battle lasting well into 2012 based on Roche's past deal playbook and possible regulatory hurdles.

Dealtalk: If U.S. blocks Express-Medco, what's Plan B?

Jan 20 2012

NEW YORK/PHILADELPHIA As healthcare mergers go, this one is unique: Express Scripts Inc will not find a target in the pharmacy benefit industry anywhere near as large as Medco Health Solutions Inc , while Medco realistically has little shot at wooing a suitor other than its chief rival.

Pharma pays up for scarce assets

Jan 10 2012

SAN FRANCISCO When it comes to healthcare deals, the new motto may be "too expensive to fail."

World News